Galkin Amends Innovative Eyewear Stake

TL;DR

Galkin filed an update on his Innovative Eyewear stake. Watch this space.

AI Summary

Vladimir Galkin has filed an amendment (Amendment No. 6) to his Schedule 13D/A for Innovative Eyewear, Inc., on October 2, 2024. The filing indicates a change in beneficial ownership of the company's common stock. Galkin's address is listed as 10900 NW 97th Street, #102, Miami, FL 33178.

Why It Matters

This filing signals a potential shift in control or significant shareholder activity for Innovative Eyewear, Inc., which could impact its stock price and strategic direction.

Risk Assessment

Risk Level: medium — Schedule 13D filings often indicate significant shareholder activity that can lead to volatility.

Key Players & Entities

• Vladimir Galkin (person) — Filing person and potential beneficial owner
• Innovative Eyewear, Inc. (company) — Subject company
• October 2, 2024 (date) — Date of event requiring filing
• Amendment No. 6 (document) — Type of filing

FAQ

Key Financial Figures

• $0.00001 — me of Issuer) Common Stock, par value $0.00001 per share (Title of Class of Securiti

Filing Documents

• vg_sc13dz.htm (SC 13D/A) — 45KB
• 0001376474-24-000572.txt ( ) — 47KB

Security and Issuer

ITEM 1. Security and Issuer This Amendment No. 6 amends the Schedule 13D filed on September 23, 2024 (the "Original Schedule 13D" and, as amended by Amendment No. 1 to Schedule 13D filed on September 23, 2024, and as amended by Amendment No.2 to Schedule 13D filed on September 23, 2024 , and as amended by Amendment No. 3 filed on September 23, 2024, and as amended by Amendment No. 4 filed on September 24, 2024, and as amended by Amendment No. 5 filed on September 25, 2024, as amended the "Schedule 13D"). This statement of beneficial ownership on Schedule 13D is jointly filed by each of Vladimir Galkin and Angelica Galkin, husband and wife (collectively, the "Reporting Persons" and individually, a "Reporting Person"), with respect to the shares of the common stock, par value $0.00001 per share (the " Common Stock"), of Innovative Eyewear, Inc., a Florida corporation (the " Issuer") . According to the Issuer, the address of its principal executive office is 1900 Biscayne Blvd., Suite 630, North Miami, Florida 33181. Unless specifically amended hereby, the disclosures set forth in the Original Schedule 13D remain unchanged. Capitalized terms used but not otherwise defined herein have the meanings given to them in the Original Schedule 13D filed on September 23, 2024.

Purpose of Transaction

ITEM 4. Purpose of Transaction The Reporting Persons acquired the securities reported herein for investment in the ordinary course of business because of their belief that the Issuer represents an attractive investment based on the Issuer's business prospects and strategy. The Reporting Persons may communicate with the board of directors of the Issuer (the "Board"), members of management and/or other shareholders or other relevant parties from time to time with respect to operational, strategic, financial or governance matters or otherwise work with management and the Board with a view to maximizing shareholder value. In addition, the Reporting Persons have had, and intend to continue to have, discussions with members of the Issuer's management and board of directors regarding the possibility of board representation. The Reporting Persons reserve the right to acquire, or cause to be acquired, additional securities of the Issuer, to dispose of, or cause to be disposed of, such securities at any time or to formulate other purposes, plans or proposals regarding the Issuer or any of its securities, to the extent deemed advisable in light of general investment and trading policies of the Reporting Persons, market conditions or other factors. Other than as set forth above, the Reporting Persons do not have any plans or proposals as of the date of this filing which relate to or would result in any of the actions enumerated in Item 4 of the instructions to Schedule 13D.

Interest in Securities of the Issuer

ITEM 5. Interest in Securities of the Issuer . Item 5(a) of the Schedule 13D is hereby amended to read in its entirety as follows (all other disclosures in Item 5 remain unchanged): (a) As of the date hereof, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own 1,000,000 shares of Common Stock, representing approximately 41.7% of the issued and outstanding shares of Common Stock of Issuer. The foregoing beneficial ownership percentages reported in this Item 5 are based on 2,400,452 shares of the Issuer's Common Stock issued and outstanding as of October 2, 2024, based on information reported by the Issuer in the Registration Statement on Form S-1 and filed with the Securities and Exchange Commission (the "SEC") on October 2, 2024.

Material to Be Filed as Exhibits

ITEM 7. Material to Be Filed as Exhibits . 1. Exhibit A - Joint Filing Agreement of the Reporting Persons. 13D CUSIP No. 45791D109 Page 5 of 5 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: October 4, 2024 By: /s/ Vladimir Galkin Vladimir Galkin Date: October 4, 2024 By: /s/ Angelica Galkin Angelica Galkin 13D Exhibit A JOINT FILING AGREEMENT This Joint Filing Agreement (this "Agreement") hereby confirms the agreement by and among all of the undersigned that the Schedule 13D to which this Agreement is attached as Exhibit A, with respect to the beneficial ownership of the undersigned shares of common stock of Innovative Eyewear, Inc, is being filed on behalf of each of the undersigned. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Date: October 4, 2024 By: /s/ Vladimir Galkin Vladimir Galkin Date: October 4, 2024 By: /s/ Angelica Galkin Angelica Galkin

View Full Filing

View this SC 13D/A filing on SEC EDGAR